We are live on ! Find out more
DFO

Duquesne Family Office Portfolio holdings

AUM $5.21B
1-Year Est. Return 87.01%
This Fund
S&P 500
This Quarter Est. Return
+2.36%
1 Year Est. Return
+87.01%
3 Year Est. Return
+345.18%
5 Year Est. Return
+545.74%
10 Year Est. Return
+5,317.36%
AUM
$815M
AUM Growth
-$586M
Cap. Flow
-$570M
Cap. Flow %
-69.95%
Top 10 Hldgs %
56.84%
Holding
69
New
24
Increased
2
Reduced
5
Closed
33

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$25.7M
2
GILD icon
Gilead Sciences
GILD
+$21.3M
3
AMGN icon
Amgen
AMGN
+$20.7M
4
MRK icon
Merck
MRK
+$19.4M
5
COST icon
Costco
COST
+$19.1M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$129M
2
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$65.1M
3
META icon
Meta Platforms (Facebook)
META
+$63.8M
4
GDX icon
VanEck Gold Miners ETF
GDX
+$60M
5
WBA
Walgreens Boots Alliance
WBA
+$38.8M

Sector Composition

Rank Sector Weight
1 Healthcare 35.39%
2 Consumer Discretionary 16.43%
3 Communication Services 12.04%
4 Materials 7.93%
5 Miscellaneous 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
51
Humana
HUM
$46.6B
– –
-83,900
Closed -$10.7M
LEN icon
52
Lennar Class A
LEN
$19.4B
– –
-389,128
Closed -$15.5M
META icon
53
Meta Platforms (Facebook)
META
$1.72T
– –
-948,500
Closed -$63.8M
MPC icon
54
Marathon Petroleum
MPC
$117B
– –
-246,800
Closed -$9.63M
NXPI icon
55
NXP Semiconductors
NXPI
$56.7B
– –
-324,400
Closed -$21.5M
OXY icon
56
Occidental Petroleum
OXY
$60.2B
– –
-107,926
Closed -$10.6M
PBR icon
57
Petrobras
PBR
$136B
– –
-1,717,000
Closed -$25.1M
PSX icon
58
Phillips 66
PSX
$106B
– –
-303,200
Closed -$24.4M
RRC icon
59
Range Resources
RRC
$9.28B
– –
-363,400
Closed -$31.6M
SPY icon
60
State Street SPDR S&P 500 ETF Trust
SPY
$802B
– –
-51,100
Closed -$10M
TEVA icon
61
Teva Pharmaceutical Industries Limited
TEVA
$45.6B
– –
-1,241,000
Closed -$65.1M
VLO icon
62
Valero Energy
VLO
$115B
– –
-198,500
Closed -$9.95M
XLB icon
63
State Street Materials Select Sector SPDR ETF
XLB
$8.43B
– –
-405,200
Closed -$10.1M
XLI icon
64
State Street Industrial Select Sector SPDR ETF
XLI
$30.9B
– –
-183,300
Closed -$9.91M
XLK icon
65
State Street Technology Select Sector SPDR ETF
XLK
$121B
– –
-788,800
Closed -$15.1M
SPWR
66
DELISTED
SunPower Corporation Common Stock
SPWR
– –
-382,972
Closed -$10.3M
PXD
67
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-99,800
Closed -$22.9M
SNDK
68
DELISTED
SANDISK CORP
SNDK
– –
-330,600
Closed -$34.5M
DISH
69
DELISTED
DISH Network Corp.
DISH
– –
-414,500
Closed -$27M
1 2
3

Similar funds

LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $5.2B AUM 22.05% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
CFC
Cincinnati Financial Corp Fairfield, Ohio $5.23B AUM 22.72% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $5.24B AUM 38.12% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.16B AUM 18.64% 1-Year Est. Return

Duquesne Family Office's Q3 2014 Portfolio in Review

As of Q3 2014, Duquesne Family Office held 69 positions worth $815M, down 42% from $1.4B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Duquesne Family Office withdrew a net $570M in Q3 2014, closing 33 positions and reducing 5 holdings. Its most notable exit was Teva Pharmaceutical Industries Limited, an estimated $65.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Duquesne Family Office opened a new position in Gilead Sciences worth $23.2M.

  • Duquesne Family Office's largest Q3 2014 buy was Gilead Sciences: 217,500 shares worth $23.2M.
  • Duquesne Family Office added most to Celgene Corp in Q3 2014, an estimated $25.7M increase.
  • Duquesne Family Office's biggest Q3 2014 reduction was Alphabet (Google) Class C, cutting an estimated $129M.
  • Duquesne Family Office fully exited Teva Pharmaceutical Industries Limited in Q3 2014, selling an estimated $65.1M.
  • Duquesne Family Office's ten largest holdings make up 57% of its $815M portfolio in Q3 2014.
  • Duquesne Family Office opened 24 new positions and closed 33 in Q3 2014.
  • Duquesne Family Office's portfolio value fell 42% quarter-over-quarter to $815M.

Based on Duquesne Family Office's 13F filing for Q3 2014, filed 14 Nov 2014.